December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Dr. Reddy's Laboratories Ltd Common Stock (NY:RDY)

12.77 -0.32 (-2.44%)
Official Closing Price Updated: 6:30 PM EDT, Apr 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dr. Reddy's Laboratories Ltd Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Dr Reddy's Rolls Out Sputnik V COVID-19 Vaccine In India At $13.58/Dose ↗
Dr. Reddy's Laboratories Ltd (NYSE: RDY) said that it expects to get 36 million doses of Sputnik V COVID-19 vaccine in the next couple of months under its... 
Via Benzinga
News headline image
Dr. Reddy's Laboratories Announces the Launch of Ertapenem for Injection in the U.S. Market
From Dr. Reddy’s Laboratories Ltd.
Via Business Wire
News headline image
Heavy Global Erosion ↗
It is an everything-down day. Even the news is down because commenters are being careful. 
Via Talk Markets
News headline image
Why Is No One Talking About Dr. Reddy's Stock? ↗
The large generics manufacturer's share price is up more than 35% over the past year. 
Via The Motley Fool
News headline image
Gold Up Four Days In A Row ↗
The dollar is at a nearly 3 month low. 
Via Talk Markets
News headline image
3 Global Value Stocks to Buy Now ↗
Tired of expensive stocks being just of reach? Look abroad for some great buying opportunities. 
Via The Motley Fool
News headline image
Another Heavy News Day ↗
For whatever it is worth, markets seem keen on the proposed measures, boosted by a nicely lower level of new unemployment insurance claims last week. 
Via Talk Markets
News headline image
Dr. Reddy's Laboratories Announces the Launch of Albendazole Tablets, USP in the U.S. Market
From Dr. Reddy’s Laboratories Ltd.
Via Business Wire
News headline image
Merck Teams Up With Five Indian Generic Players To Expand COVID-19 Drug Access, Production ↗
Merck & Co Inc (NYSE: MRK) has partnered with five Indian generic drugmakers to expand production and access to Molnupiravir, its experimental oral... 
Via Benzinga
News headline image
Friday Market Report ↗
Schlumberger Ltd of Curação today reported on its Q1 results which were good. 
Via Talk Markets
News headline image
Gold Is Back ↗
Wednesday was another mixed day with oil stocks and foreign telcos up from demand rising--but US telcos going their own ways, with AT&T up, and Verizon down because it lost wireless subs. 
Via Talk Markets
News headline image
Electric Cancer Cure ↗
Most US stocks were down on fear of inflation and financial risks but then rose after lunch. 
Via Talk Markets
News headline image
Dr. Reddy's Laboratories Gets Emergency Use Authorisation for Sputnik V in India
From Dr. Reddy’s Laboratories Ltd.
Via Business Wire
News headline image
Dr. Reddy's Stock Is Trading Higher As Sputnik V Vaccine Gets Emergency Use Nod In India: Report ↗
The panel of India’s Central Drugs Standard Control Organization (CDSCO) has recommended the emergency use authorization of Russia’s Sputnik V coronavirus vaccine,... 
Via Benzinga
News headline image
Heavy News Day - Cheats ↗
US job losses were up 744,000 vs a forecast of 694,000. 
Via Talk Markets
News headline image
Dr. Reddy's Laboratories Announces the Launch of a Generic Version of Sapropterin Dihydrochloride Powder for Oral Solution, 100 mg in the U.S. Market
From Dr. Reddy’s Laboratories Ltd.
Via Business Wire
News headline image
Britain Is Back ↗
England is going to reopen earlier than expected thanks to the speedy rollout of Covid-19 inoculation. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.